COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,575 Articles (22,415 medRxiv, 8,160 bioRxiv)

Most recent first Previous |  Page 2883: Articles 28821-28830  | Next

A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2
Weiss, S., Klingler, J., Hioe, C., Amanat, F., Baine, I., Kojic, E. M., Stoever, J., Liu, S., Jurczyszak, D., Bermudez-Gonzalez, M., Simon, V., Krammer, F., Zolla-Pazner, S.
10.1101/2020.04.14.20059501 — Posted: 2020-04-17
An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area
Meng, Z., Wang, T., Li, C., Chen, X., Li, L., Qin, X., Li, H., Luo, J.
10.1101/2020.04.11.20061473 — Posted: 2020-04-17 Discussion: Onsite
Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol
Verdugo-Paiva, F., Izcovich, A., Ragusa, M., Rada, G., COVID-19 L-OVE Working Group
10.1101/2020.04.11.20062109 — Posted: 2020-04-17
The Estimated Time-Varying Reproduction Numbers during the Ongoing Epidemic of the Coronavirus Disease 2019 (COVID-19) in China
Hu, F.-C., Wen, F.-Y.
10.1101/2020.04.11.20061838 — Posted: 2020-04-17 Discussion: Offsite
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view
Momekov, G., Momekova, D.
10.1101/2020.04.11.20061804 — Posted: 2020-04-17 Discussion: Onsite
Public policy and economic dynamics of COVID-19 spread: a mathematical modeling study
Goldsztejn, U., Schwartzman, D., Nehorai, A.
10.1101/2020.04.13.20062802 — Posted: 2020-04-17 Discussion: Onsite
Coronavirus epidemic: prediction and controlling measures
Pejman, M. M., fereidooni, a.
10.1101/2020.04.11.20062125 — Posted: 2020-04-17
Shut it down: a cross country panel analysis on the efficacy of lockdown measures
Alfano, V., Ercolano, S.
10.1101/2020.04.12.20062695 — Posted: 2020-04-17
EFFECTIVENESS OF BASELINE AND POST-PROCESSED CHEST X-RAY IN NONEARLY COVID-19 PATIENTS
Gaeta, M., Cicero, G., Marino, M. A., D'Angelo, T., Mormina, E. M., Mazziotti, S., Blandino, A., Siracusano, G., La Corte, A., Chiappini, M., Finocchio, G.
10.1101/2020.04.16.20061044 — Posted: 2020-04-17
Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide
Ayoub, H. H., Chemaitelly, H., Seedat, S., Mumtaz, G. R., Makhoul, M., Abu-Raddad, L. J.
10.1101/2020.04.13.20059253 — Posted: 2020-04-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).